KLF7: A Potential Drug Target and Biomarker (G8609)

Target Name: KLF7

NCBI ID: G8609

KLF7

KLF7: A Potential Drug Target and Biomarker

Kruppel-like factor 7 (KLF7) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. KLF7 is a key regulator of gene expression in various organisms, including humans. It is a member of the Kruppel family, which includes several similar non-coding RNAs that play important roles in cellular processes. KLF7 has been shown to play a role in the regulation of cell adhesion, migration, and invasion, as well as in the development and progression of various diseases, including cancer.

The discovery of KLF7 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. KLF7 has been shown to be involved in several cellular processes that are implicated in the development and progression of various diseases, including cancer. For example, KLF7 has been shown to be involved in the regulation of cell adhesion, which is critical for the development of cancer cells. In addition, KLF7 has been shown to be involved in the regulation of cell migration and invasion, which are also critical for the development of cancer.

KLF7 has also been shown to be involved in the regulation of apoptosis, which is a critical process that helps regulate cell death. Apoptosis is a natural process that helps remove damaged or dysfunctional cells from the body, which is important for maintaining tissue homeostasis and preventing the development of diseases. However, abnormal apoptosis can contribute to the development and progression of many diseases, including cancer. Therefore, the regulation of apoptosis by KLF7 may be an attractive target for new drugs that can promote healthy cell death and prevent the development of cancer.

In addition to its potential role as a drug target, KLF7 has also been shown to be a potential biomarker for several diseases, including cancer. The regulation of gene expression by KLF7 has been shown to be associated with the development and progression of various diseases, including cancer. For example, studies have shown that KLF7 is downregulated in various tissues and organisms that are susceptible to cancer, and that restoring KLF7 expression to normal levels may be an effective way to prevent the development of cancer. In addition, KLF7 has been shown to be associated with the expression of certain genes that are known to be involved in the development and progression of cancer. Therefore, measuring KLF7 expression levels may be a useful way to monitor the effectiveness of new treatments for cancer.

KLF7 has also been shown to play a role in the regulation of stem cell maintenance and proliferation. Stem cells are a type of cell that have the ability to develop into any type of cell in the body, and they play a critical role in the development and maintenance of tissues and organs. The regulation of stem cell maintenance and proliferation by KLF7 may be an important target for the development of new treatments for diseases that are caused by the destruction of stem cells, such as cancer.

In conclusion, KLF7 is a non-coding RNA molecule that has been shown to play a role in several cellular processes that are important for the development and progression of various diseases, including cancer. The regulation of cell adhesion, migration, and invasion, as well as the regulation of apoptosis, by KLF7 may make it an attractive target for the development of new drugs that can promote healthy cell death and prevent the development of cancer. In addition, KLF7 has also been shown to be involved in the regulation of stem cell maintenance and proliferation, which may make it an important target for the development of new treatments for diseases caused by the destruction of stem cells. Further research is needed to fully understand the role of KLF7 in these processes and to develop new treatments based on this information.

Protein Name: KLF Transcription Factor 7

Functions: Transcriptional factor (PubMed:9774444, PubMed:16339272). Plays a critical role in neuronal morphogenesis and survival of sensory neurons (By similarity). Represses the corneal epithelium differentiation (PubMed:28916725). Acts also as a metabolic regulator, by modulating insulin sensitivity in pancreatic beta cells and skeletal muscle cells (PubMed:16339272). Inhibits transcriptional inducers of adipogenesis and has a repressive role in the expression of several adipokines, including leptin (PubMed:16339272)

The "KLF7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLF7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets